OAS1 and COVID-19: Genetic variations within IFNAR2, OAS1, and OAS3 could potentially disrupt this signaling pathway, leading to decreased protein abundance, impaired receptor internalization, or altered ligand interactions, thereby exacerbating the severity of COVID-19 [65,77,83].